Johnson & Johnson (NYSE: JNJ) is the latest pharma company to provide results from the trial of its COVID-19 vaccine candidate. The company
Johnson & Johnson’s (JNJ) single-dose vaccine is effective but lags behind rivals
Categories
Research Summary
Johnson & Johnson (JNJ): Strength in ecommerce drives growth in Consumer Health
Shares of Johnson & Johnson (NYSE: JNJ) gained nearly 3% in morning trade on Tuesday after the company reported fourth quarter 2020
Merck (MRK) pulls out of the COVID-19 vaccine race; will focus on investigational therapeutic candidates
Merck & Co. Inc. (NYSE: MRK) has decided to discontinue the development of its COVID-19 vaccine candidates after its clinical trials yielded
What to make of GameStop’s (GME) inexplicable rally
GameStop Corp. (NYSE: GME) is witnessing a rally like none before. Shares surged 35% in morning trade on Monday. The stock has
Strong digital sales change the face of Target’s (TGT) holiday shopping
Target Corporation (NYSE: TGT) reported double-digit growth in comparable sales during the holiday season. The company saw a massive spike in demand
Carnival Corporation (CCL): Despite headwinds, there is a positive sentiment around the stock
Without doubt, Carnival Corporation (NYSE: CCL) did not have a good year in 2020. The COVID-19 pandemic halted its operations and negatively
Moderna (MRNA): Development programs, additional approvals provide optimism
Moderna Inc. (NASDAQ: MRNA) seems to be on a roll right now. The stock has skyrocketed over 500% in the past one
Trxade Group Inc. (NASDAQ: MEDS) Q4 2020 Research Summary
Ticker MEDSExchange NASDAQFounded 2013Headquarters FloridaIndustry TechnologyMarket Cap $45 million Trxade Group Inc (NASDAQ: MEDS) has been serving pharmacies and drug manufacturers for
Moderna’s (MRNA) stock gains on COVID-19 vaccine approval from the European Commission
Shares of Moderna Inc. (NASDAQ: MRNA) gained 6.3% in afternoon hours on Wednesday as the company received approval from the European Commission
360 DigiTech (NASDAQ: QFIN) Q4 2020 Research Summary
360 DigiTech, Inc. (NASDAQ: QFIN) has carved a niche for itself in China's financial service sector with a unique business model that
Trxade Group Inc. (NASDAQ: MEDS) Q3 2020 Research Summary
Ticker MEDSExchange NASDAQFounded 2013Headquarters FloridaIndustry TechnologyMarket Cap $49 million Trxade Group (NASDAQ: MEDS) operates a web-based purchasing platform that brings together independent
360 DigiTech (NASDAQ: QFIN) Q3 2020 Research Summary
360 DigiTech, Inc. (NASDAQ: QFIN) is a market leader in online consumer finance, with a special focus on underserved borrowers. It offers
360 Finance (NASDAQ: QFIN) Q2 2020 Research Summary
TickerQFINExchangeNASDAQFounded 2016Headquarters ChinaIndustryFinancial ServicesMarket CapUS$1.99 billionEmployees1,891 Incorporated in 2016, 360 Finance Inc. (NASDAQ: QFIN) has carved a niche for itself in the
How well is Costco Wholesale Corporation placed to ride the Covid-19 Pandemic?
Costco Wholesale Corporation (NASDAQ: COST) has always been a step ahead of other retailers, thanks to its membership-based model and loyal customer
Wealth management: Who do you trust?
Binod Shankar CFA Hit by the shock of the 2008 financial crisis and ongoing scandals around money laundering, rogue trading, rate manipulation,
Financial Analysis In Special Situations
Binod Shankar CFA Whether you are an owner, FP&A manager, banker, equity analyst, or an investor, what numbers and ratios should you
Alteryx (AYX) stock research summary
Value investors are constantly on the lookout for high-performance stocks at discounted rates. The lucrative SaaS industry has a lot on offer
Research Tear Sheet: Advanced Micro Devices (NASDAQ: AMD) stock
While the slowdown witnessed in the semiconductor industry late last year and the first half of this year seems to have finally
Research Tear Sheet: Village Farms International (VFF) stock
Last year, Canada became the breeding ground for numerous pot stocks following the country’s decision to legalize the use of marijuana for
What is NASH and which biotech firms are vying for the first-mover status
NASH, or Nonalcoholic steatohepatitis, is undeniably a golden goose in the pharma space. The biggest corporate attraction towards this liver disorder is
Luxembourg creates national ‘AI lab’ with NVIDIA
Luxembourg, one of the smallest countries in Europe, joined hands with microchip and graphics card giant Nvidia (NVDA) to launch a national